Gene Therapy On Neurological Diseases Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Gene Therapy On Neurological Diseases Market Report 2026

Name: Gene Therapy On Neurological Diseases Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Viral Gene Therapy, Non-Viral Gene Therapy), By Target Disease (Alzheimer's Disease, Parkinsons Disease, Amyotrophic Lateral Sclerosis (ALS), Huntington's Disease, Multiple Sclerosis), By Administration Route (Intravenous, Intrathecal, Intranasal, Intracerebral, Other Administration Routes), By Application (Hospital, Clinic, Other Applications) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Gene Therapy On Neurological Diseases Market Overview

• Gene Therapy On Neurological Diseases market size has reached to $3.55 billion in 2025

• Expected to grow to $6.48 billion in 2030 at a compound annual growth rate (CAGR) of 12.7%

• Growth Driver: Increasing Prevalence Of Neurological Disorders Fueling The Growth Of The Market Due To Aging Population And Rising Disease Burden

• Market Trend: One-Time Therapy Offers Long-Lasting Benefits And Improved Motor Function

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Gene Therapy On Neurological Diseases Market?

Gene therapy on neurological diseases refers to the use of genetic material to treat or prevent disorders that affect the brain, spinal cord, and nervous system. It involves delivering corrective genes into a patient’s cells using viral or non-viral vectors to address the underlying genetic causes of neurological conditions. It is used to restore normal gene function, slow disease progression, or alleviate symptoms by targeting the root genetic causes rather than just managing symptoms.

The main types of gene therapy on neurological diseases are viral gene therapy and non-viral gene therapy. Viral gene therapy involves the use of engineered viruses as delivery vectors to transport therapeutic genes into a patient’s cells to treat or prevent diseases. These therapies target various neurological conditions, including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), Huntington’s disease, and multiple sclerosis. They are administered through different routes such as intravenous, intrathecal, intranasal, intracerebral, and others, and are applied across various settings, including hospitals, clinics, and others.

Gene Therapy On Neurological Diseases Market Global Report 2026 Market Report bar graph

What Is The Gene Therapy On Neurological Diseases Market Size and Share 2026?

The gene therapy on neurological diseases market size has grown rapidly in recent years. It will grow from $3.55 billion in 2025 to $4.01 billion in 2026 at a compound annual growth rate (CAGR) of 13.0%. The growth in the historic period can be attributed to limited gene therapy options for neurological diseases, growing prevalence of alzheimer's and parkinsons disease, reliance on conventional treatment methods, increasing awareness of genetic approaches, early clinical trials of viral vectors.

What Is The Gene Therapy On Neurological Diseases Market Growth Forecast?

The gene therapy on neurological diseases market size is expected to see rapid growth in the next few years. It will grow to $6.48 billion in 2030 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to development of adeno associated virus and lentiviral therapies, expansion of non-viral delivery platforms, increasing regulatory approvals for neurological gene therapies, rising investment in r&d for targeted genetic interventions, integration of digital monitoring and AI-based patient management. Major trends in the forecast period include rising investment in viral and non-viral gene therapy platforms, expansion of gene therapy applications across neurological disorders, increasing focus on personalized and targeted genetic treatments, growth in hospital and clinic-based gene therapy programs, development of advanced delivery methods for neurological gene therapy.

Book your 30 minutes free consultation with our research experts

Global Gene Therapy On Neurological Diseases Market Segmentation

1) By Type: Viral Gene Therapy, Non-Viral Gene Therapy

2) By Target Disease: Alzheimer's Disease, Parkinsons Disease, Amyotrophic Lateral Sclerosis (ALS), Huntington's Disease, Multiple Sclerosis

3) By Administration Route: Intravenous, Intrathecal, Intranasal, Intracerebral, Other Administration Routes

4) By Application: Hospital, Clinic, Other Applications

Subsegments:

1) By Viral Gene Therapy Type: Adeno Associated Virus, Lentivirus, Retrovirus, Herpes Simplex Virus, Adenovirus

2) By Non-Viral Gene Therapy Type: Liposomes, Nanoparticles, Electroporation, Gene Gun, Naked Plasmid Deoxyribonucleic Acid (DNA)

What Is The Driver Of The Gene Therapy On Neurological Diseases Market?

The increasing prevalence of neurological disorders is expected to propel the growth of the gene therapy on neurological diseases market going forward. Neurological disorders are medical conditions that affect the brain, spinal cord, and nerves, leading to a range of symptoms, including cognitive, motor, and sensory impairments. The increasing prevalence of neurological disorders is linked to the aging population, as aging gradually impairs neuronal function, reduces brain plasticity, and elevates oxidative stress, contributing to the development and progression of these conditions. Gene therapy on neurological diseases aids in neurological disorder management by targeting the root genetic causes, offering potential long-term or permanent treatment solutions. It improves patient outcomes by restoring or modifying gene function, reducing symptoms, and minimizing the need for repetitive interventions, thereby enhancing overall quality of life. For instance, in July 2024, according to the National Health Service, a UK-based government agency, there were 487,432 patients diagnosed with dementia (a progressive brain disorder affecting memory, thinking, and daily activities) by June 30, 2024, an increase of 3,155 cases compared to May 31, 2024. Therefore, the increasing prevalence of neurological disorders is driving the growth of the gene therapy on neurological diseases industry.

Key Players In The Global Gene Therapy On Neurological Diseases Market

Major companies operating in the gene therapy on neurological diseases market are Novartis AG, Biogen Inc., Sarepta Therapeutics Inc., PTC Therapeutics Inc., Oxford Biomedica plc, Regenxbio Inc., Passage Bio Inc., Intellia Therapeutics Inc., Voyager Therapeutics Inc., UniQure N.V., AviadoBio Ltd., Capsida Biotherapeutics Inc., StrideBio Inc., Lysogene S.A., Wave Life Sciences Ltd., Taysha Gene Therapies Inc., Abeona Therapeutics Inc., CRISPR Therapeutics AG

Global Gene Therapy On Neurological Diseases Market Trends and Insights

Major companies operating in the gene therapy on neurological diseases market are focusing on developing advanced viral delivery systems, such as adeno-associated virus serotype 2 (AAV2) vector, to improve targeted gene delivery, enhance efficacy, reduce immune reactions, and enable long-lasting treatments. Adeno-associated virus serotype 2 (AAV2) vector refers to a modified, non-pathogenic viral delivery system used in gene therapy to transport therapeutic genes into target cells, particularly neurons, for long-term expression. For instance, in November 2024, PTC Therapeutics Inc., a US-based biopharmaceutical company, received U.S. Food and Drug Administration (FDA) approval for gene therapy for the treatment of aromatic L-amino acid decarboxylase (AADC) deficiency. This therapy uses an AAV2 vector to deliver a functional copy of the DDC gene into the putamen, enabling dopamine production and improving motor functions. It features a one-time, intraputaminal infusion designed to provide sustained therapeutic benefits, significantly improving motor function and reducing debilitating symptoms without the need for repeated interventions.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Gene Therapy On Neurological Diseases Market?

In January 2023, Neurocrine Biosciences Inc., a US-based biotechnology company, partnered with Voyager Therapeutics, Inc. to advance multiple next-generation gene therapies for neurological diseases. With this partnership, Neurocrine and Voyager aim to accelerate development and commercialization by combining Voyager’s TRACER capsid platform-enabled GBA1 gene therapy and other CNS-targeted AAV programs with Neurocrine’s expertise in neuroscience and clinical development, while sharing risks, aligning on cost and profit-sharing, and pursuing novel treatments for Parkinson’s disease, Friedreich’s ataxia, and other rare CNS conditions. Voyager Therapeutics Inc. is a US-based gene-therapy company that specializes in developing AAV-based gene therapies with enhanced blood–brain-barrier penetration for central nervous system disorders.

Regional Insights

North America was the largest region in the gene therapy on neurological diseases market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Gene Therapy On Neurological Diseases Market?

The gene therapy on neurological diseases market consists of revenues earned by entities by providing services such as gene delivery and vector development, clinical trial services, personalised therapy development, regulatory consulting and compliance, and manufacturing support. The market value includes the value of related goods sold by the service provider or included within the service offering. The gene therapy on neurological diseases market also includes sales of gene therapy vectors, plasmid deoxyribonucleic acid (DNA), ribonucleic acid (RNA)-based therapeutics, cell lines and reagents, and neurologically targeted gene therapies. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Gene Therapy On Neurological Diseases Market Report 2026?

The gene therapy on neurological diseases market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gene therapy on neurological diseases industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Gene Therapy On Neurological Diseases Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$4.01 billion
Revenue Forecast In 2035	$6.48 billion
Growth Rate	CAGR of 13.0% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Target Disease, Administration Route, Application
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Novartis AG, Biogen Inc., Sarepta Therapeutics Inc., PTC Therapeutics Inc., Oxford Biomedica plc, Regenxbio Inc., Passage Bio Inc., Intellia Therapeutics Inc., Voyager Therapeutics Inc., UniQure N.V., AviadoBio Ltd., Capsida Biotherapeutics Inc., StrideB
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Gene Therapy On Neurological Diseases Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Gene Therapy On Neurological Diseases Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Gene Therapy On Neurological Diseases Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Gene Therapy On Neurological Diseases Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Investment In Viral And Non-Viral Gene Therapy Platforms

4.2.2 Expansion Of Gene Therapy Applications Across Neurological Disorders

4.2.3 Increasing Focus On Personalized And Targeted Genetic Treatments

4.2.4 Growth In Hospital And Clinic-Based Gene Therapy Programs

4.2.5 Development Of Advanced Delivery Methods For Neurological Gene Therapy

5. Gene Therapy On Neurological Diseases Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Neurology Research Centers

5.4 Specialty Treatment Centers

5.5 Academic And Research Institutions

6. Gene Therapy On Neurological Diseases Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Gene Therapy On Neurological Diseases Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Gene Therapy On Neurological Diseases PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Gene Therapy On Neurological Diseases Market Size, Comparisons And Growth Rate Analysis

7.3. Global Gene Therapy On Neurological Diseases Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Gene Therapy On Neurological Diseases Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Gene Therapy On Neurological Diseases Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Gene Therapy On Neurological Diseases Market Segmentation

9.1. Global Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Viral Gene Therapy, Non-Viral Gene Therapy

9.2. Global Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Alzheimer's Disease, Parkinsons Disease, Amyotrophic Lateral Sclerosis (ALS), Huntington's Disease, Multiple Sclerosis

9.3. Global Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Intravenous, Intrathecal, Intranasal, Intracerebral, Other Administration Routes

9.4. Global Gene Therapy On Neurological Diseases Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital, Clinic, Other Applications

9.5. Global Gene Therapy On Neurological Diseases Market, Sub-Segmentation Of Viral Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adeno Associated Virus, Lentivirus, Retrovirus, Herpes Simplex Virus, Adenovirus

9.6. Global Gene Therapy On Neurological Diseases Market, Sub-Segmentation Of Non-Viral Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Liposomes, Nanoparticles, Electroporation, Gene Gun, Naked Plasmid Deoxyribonucleic Acid (DNA)

10. Gene Therapy On Neurological Diseases Market Regional And Country Analysis

10.1. Global Gene Therapy On Neurological Diseases Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Gene Therapy On Neurological Diseases Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Gene Therapy On Neurological Diseases Market

11.1. Asia-Pacific Gene Therapy On Neurological Diseases Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Gene Therapy On Neurological Diseases Market, Segmentation By Type, Segmentation By Target Disease, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Gene Therapy On Neurological Diseases Market

12.1. China Gene Therapy On Neurological Diseases Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Gene Therapy On Neurological Diseases Market, Segmentation By Type, Segmentation By Target Disease, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Gene Therapy On Neurological Diseases Market

13.1. India Gene Therapy On Neurological Diseases Market, Segmentation By Type, Segmentation By Target Disease, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Gene Therapy On Neurological Diseases Market

14.1. Japan Gene Therapy On Neurological Diseases Market Overview

14.2. Japan Gene Therapy On Neurological Diseases Market, Segmentation By Type, Segmentation By Target Disease, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Gene Therapy On Neurological Diseases Market

15.1. Australia Gene Therapy On Neurological Diseases Market, Segmentation By Type, Segmentation By Target Disease, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Gene Therapy On Neurological Diseases Market

16.1. Indonesia Gene Therapy On Neurological Diseases Market, Segmentation By Type, Segmentation By Target Disease, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Gene Therapy On Neurological Diseases Market

17.1. South Korea Gene Therapy On Neurological Diseases Market Overview

17.2. South Korea Gene Therapy On Neurological Diseases Market, Segmentation By Type, Segmentation By Target Disease, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Gene Therapy On Neurological Diseases Market

18.1. Taiwan Gene Therapy On Neurological Diseases Market Overview

18.2. Taiwan Gene Therapy On Neurological Diseases Market, Segmentation By Type, Segmentation By Target Disease, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Gene Therapy On Neurological Diseases Market

19.1. South East Asia Gene Therapy On Neurological Diseases Market Overview

19.2. South East Asia Gene Therapy On Neurological Diseases Market, Segmentation By Type, Segmentation By Target Disease, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Gene Therapy On Neurological Diseases Market

20.1. Western Europe Gene Therapy On Neurological Diseases Market Overview

20.2. Western Europe Gene Therapy On Neurological Diseases Market, Segmentation By Type, Segmentation By Target Disease, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Gene Therapy On Neurological Diseases Market

21.1. UK Gene Therapy On Neurological Diseases Market, Segmentation By Type, Segmentation By Target Disease, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Gene Therapy On Neurological Diseases Market

22.1. Germany Gene Therapy On Neurological Diseases Market, Segmentation By Type, Segmentation By Target Disease, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Gene Therapy On Neurological Diseases Market

23.1. France Gene Therapy On Neurological Diseases Market, Segmentation By Type, Segmentation By Target Disease, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Gene Therapy On Neurological Diseases Market

24.1. Italy Gene Therapy On Neurological Diseases Market, Segmentation By Type, Segmentation By Target Disease, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Gene Therapy On Neurological Diseases Market

25.1. Spain Gene Therapy On Neurological Diseases Market, Segmentation By Type, Segmentation By Target Disease, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Gene Therapy On Neurological Diseases Market

26.1. Eastern Europe Gene Therapy On Neurological Diseases Market Overview

26.2. Eastern Europe Gene Therapy On Neurological Diseases Market, Segmentation By Type, Segmentation By Target Disease, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Gene Therapy On Neurological Diseases Market

27.1. Russia Gene Therapy On Neurological Diseases Market, Segmentation By Type, Segmentation By Target Disease, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Gene Therapy On Neurological Diseases Market

28.1. North America Gene Therapy On Neurological Diseases Market Overview

28.2. North America Gene Therapy On Neurological Diseases Market, Segmentation By Type, Segmentation By Target Disease, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Gene Therapy On Neurological Diseases Market

29.1. USA Gene Therapy On Neurological Diseases Market Overview

29.2. USA Gene Therapy On Neurological Diseases Market, Segmentation By Type, Segmentation By Target Disease, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Gene Therapy On Neurological Diseases Market

30.1. Canada Gene Therapy On Neurological Diseases Market Overview

30.2. Canada Gene Therapy On Neurological Diseases Market, Segmentation By Type, Segmentation By Target Disease, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Gene Therapy On Neurological Diseases Market

31.1. South America Gene Therapy On Neurological Diseases Market Overview

31.2. South America Gene Therapy On Neurological Diseases Market, Segmentation By Type, Segmentation By Target Disease, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Gene Therapy On Neurological Diseases Market

32.1. Brazil Gene Therapy On Neurological Diseases Market, Segmentation By Type, Segmentation By Target Disease, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Gene Therapy On Neurological Diseases Market

33.1. Middle East Gene Therapy On Neurological Diseases Market Overview

33.2. Middle East Gene Therapy On Neurological Diseases Market, Segmentation By Type, Segmentation By Target Disease, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Gene Therapy On Neurological Diseases Market

34.1. Africa Gene Therapy On Neurological Diseases Market Overview

34.2. Africa Gene Therapy On Neurological Diseases Market, Segmentation By Type, Segmentation By Target Disease, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Gene Therapy On Neurological Diseases Market Regulatory and Investment Landscape

36. Gene Therapy On Neurological Diseases Market Competitive Landscape And Company Profiles

36.1. Gene Therapy On Neurological Diseases Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Gene Therapy On Neurological Diseases Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Gene Therapy On Neurological Diseases Market Company Profiles

36.3.1. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Sarepta Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. PTC Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Oxford Biomedica plc Overview, Products and Services, Strategy and Financial Analysis

37. Gene Therapy On Neurological Diseases Market Other Major And Innovative Companies

Regenxbio Inc., Passage Bio Inc., Intellia Therapeutics Inc., Voyager Therapeutics Inc., UniQure N.V., AviadoBio Ltd., Capsida Biotherapeutics Inc., StrideBio Inc., Lysogene S.A., Wave Life Sciences Ltd., Taysha Gene Therapies Inc., Abeona Therapeutics Inc., CRISPR Therapeutics AG

38. Global Gene Therapy On Neurological Diseases Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Gene Therapy On Neurological Diseases Market

40. Gene Therapy On Neurological Diseases Market High Potential Countries, Segments and Strategies

40.1 Gene Therapy On Neurological Diseases Market In 2030 - Countries Offering Most New Opportunities

40.2 Gene Therapy On Neurological Diseases Market In 2030 - Segments Offering Most New Opportunities

40.3 Gene Therapy On Neurological Diseases Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Gene Therapy On Neurological Diseases Market, Overview Of Key Products - Product Examples

Table 2: Global Gene Therapy On Neurological Diseases Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Gene Therapy On Neurological Diseases Market, Supply Chain Analysis

Table 4: Global Gene Therapy On Neurological Diseases Market, Major Raw Material Providers

Table 5: Global Gene Therapy On Neurological Diseases Market, Major Resource Providers

Table 6: Global Gene Therapy On Neurological Diseases Market, Major Manufacturers (Suppliers)

Table 7: Global Gene Therapy On Neurological Diseases Market, Major Distributors And Channel Partners

Table 8: Global Gene Therapy On Neurological Diseases Market, Key Technologies & Future Trends

Table 9: Global Gene Therapy On Neurological Diseases Market, Major Trends

Table 10: Global Gene Therapy On Neurological Diseases Market, Major End Users

Table 11: Global Gene Therapy On Neurological Diseases Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Gene Therapy On Neurological Diseases Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Gene Therapy On Neurological Diseases Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Gene Therapy On Neurological Diseases Market - TAM, US$ Billion, 2025

Table 15: Global Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Gene Therapy On Neurological Diseases Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Gene Therapy On Neurological Diseases Market, Sub-Segmentation Of Viral Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Gene Therapy On Neurological Diseases Market, Sub-Segmentation Of Non-Viral Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Gene Therapy On Neurological Diseases Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Gene Therapy On Neurological Diseases Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Indonesia, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: South Korea, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Taiwan, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South East Asia, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Western Europe, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: UK, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Germany, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: France, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Italy, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Spain, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Eastern Europe, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Russia, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: North America, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: USA, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Canada, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: South America, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Brazil, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Middle East, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Africa, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Global Gene Therapy On Neurological Diseases Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 96: Global Gene Therapy On Neurological Diseases Market - Company Scoring Matrix

Table 97: Novartis AG Financial Performance

Table 98: Biogen Inc. Financial Performance

Table 99: Sarepta Therapeutics Inc. Financial Performance

Table 100: PTC Therapeutics Inc. Financial Performance

Table 101: Oxford Biomedica plc Financial Performance

Table 102: Global Gene Therapy On Neurological Diseases Market, Competitive Benchmarking (In USD Billions)

Table 103: Global Gene Therapy On Neurological Diseases Market, Competitive Dashboard

Table 104: Global Gene Therapy On Neurological Diseases Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 105: Global, Gene Therapy On Neurological Diseases Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 106: Global, Gene Therapy On Neurological Diseases Market Size Gain ($ Billion), Segmentation By Target Disease, 2025 – 2030

Table 107: Global, Gene Therapy On Neurological Diseases Market Size Gain ($ Billion), Segmentation By Administration Route, 2025 – 2030

List Of Figures

Figure 1: Global Gene Therapy On Neurological Diseases Market, Overview Of Key Products - Product Examples

Figure 2: Global Gene Therapy On Neurological Diseases Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Gene Therapy On Neurological Diseases Market, Supply Chain Analysis

Figure 4: Global Gene Therapy On Neurological Diseases Market, Major Raw Material Providers

Figure 5: Global Gene Therapy On Neurological Diseases Market, Major Resource Providers

Figure 6: Global Gene Therapy On Neurological Diseases Market, Major Manufacturers (Suppliers)

Figure 7: Global Gene Therapy On Neurological Diseases Market, Major Distributors And Channel Partners

Figure 8: Global Gene Therapy On Neurological Diseases Market, Key Technologies & Future Trends

Figure 9: Global Gene Therapy On Neurological Diseases Market, Major Trends

Figure 10: Global Gene Therapy On Neurological Diseases Market, Major End Users

Figure 11: Global Gene Therapy On Neurological Diseases Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Gene Therapy On Neurological Diseases Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Gene Therapy On Neurological Diseases Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Gene Therapy On Neurological Diseases Market - TAM, US$ Billion, 2025

Figure 15: Global Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Gene Therapy On Neurological Diseases Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Gene Therapy On Neurological Diseases Market, Sub-Segmentation Of Viral Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Gene Therapy On Neurological Diseases Market, Sub-Segmentation Of Non-Viral Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Gene Therapy On Neurological Diseases Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Gene Therapy On Neurological Diseases Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Indonesia, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: South Korea, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Taiwan, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South East Asia, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Western Europe, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: UK, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Germany, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: France, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Italy, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Spain, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Eastern Europe, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Russia, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: North America, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: USA, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Canada, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: South America, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Brazil, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Middle East, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Africa, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Global Gene Therapy On Neurological Diseases Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 96: Global Gene Therapy On Neurological Diseases Market - Company Scoring Matrix

Figure 97: Novartis AG Financial Performance

Figure 98: Biogen Inc. Financial Performance

Figure 99: Sarepta Therapeutics Inc. Financial Performance

Figure 100: PTC Therapeutics Inc. Financial Performance

Figure 101: Oxford Biomedica plc Financial Performance

Figure 102: Global Gene Therapy On Neurological Diseases Market, Competitive Benchmarking (In USD Billions)

Figure 103: Global Gene Therapy On Neurological Diseases Market, Competitive Dashboard

Figure 104: Global Gene Therapy On Neurological Diseases Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 105: Global, Gene Therapy On Neurological Diseases Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 106: Global, Gene Therapy On Neurological Diseases Market Size Gain ($ Billion), Segmentation By Target Disease, 2025 – 2030

Figure 107: Global, Gene Therapy On Neurological Diseases Market Size Gain ($ Billion), Segmentation By Administration Route, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Surfing Boards Market Report 2026 - Global Outlook – By Product Type (Short Boards, Longboards, Fun Boards, Foam Board), By Material (Wood, Fiberglass and Foam, Epoxy, Polyurethane, Polystyrene), By Distribution Channel ...

Mobile Gaming Market Report 2026 - Global Outlook – By Device Type (Smartphone, Smartwatch, PDA, Tablet, Other Device Types), By Operating System (Android, iOS, Windows, Other Operating Systems), By Genre (Action And Adv...

Interactive Whiteboard Market Report 2026 - Global Outlook – By Form (Fixed, Portable), By Screen Size (IWBs With a Screen Size Up To 69”, IWBs With a Screen Size Ranging From 70”–90”, IWBs With a Screen Size Above 90”),...

Mobile Learning Market Report 2026 - Global Outlook – By Software Solution (Content Development, Portable LMS, Mobile Content Authoring, M-Enablement, Mobile And Video-Based Courseware, E-Books, Interactive Assessments, ...

Paper and Paperboard Packaging Market Report 2026 - Global Outlook – By Product Type (Folding Cartons, Corrugated Boxes, Other Product Types), By Grade (Solid Bleached Sulfate, Coated Unbleached Kraft Paperboard, Folding...

Mobile 3D Market Report 2026 - Global Outlook – By Type (Tablets, Smartphones, Notebooks, Other Types), By Device Component (Image Sensors, 3D Displays), By Application (Animations, Maps And Navigation, Mobile Gaming, Mo...

Switchboard Market Report 2026 - Global Outlook – By Type ( Low-Voltage, Middle-Voltage, High-Voltage ), By Product Standard ( IEC Standard, ANSI Standard), By End Users ( Industrial, Residential, Commercial, Other End-U...

Frequently Asked Questions

How big is the Gene Therapy On Neurological Diseases Market?

The Gene Therapy On Neurological Diseases market was valued at $3.55 billion in 2025, increased to $4.01 billion in 2026, and is projected to reach $6.48 billion by 2030.

What is the Gene Therapy On Neurological Diseases market growth?

The global Gene Therapy On Neurological Diseases market is expected to grow at a CAGR of 12.7% from 2026 to 2035 to reach $6.48 billion by 2035.

Who are the key players in Gene Therapy On Neurological Diseases market?

Some Key Players in the Gene Therapy On Neurological Diseases market Include, Novartis AG, Biogen Inc., Sarepta Therapeutics Inc., PTC Therapeutics Inc., Oxford Biomedica plc, Regenxbio Inc., Passage Bio Inc., Intellia Therapeutics Inc., Voyager Therapeutics Inc., UniQure N.V., AviadoBio Ltd., Capsida Biotherapeutics Inc., StrideBio Inc., Lysogene S.A., Wave Life Sciences Ltd., Taysha Gene Therapies Inc., Abeona Therapeutics Inc., CRISPR Therapeutics AG .

What is the anticipated growth trend for the Gene Therapy On Neurological Diseases market?

Major trend in this market includes: One-Time Therapy Offers Long-Lasting Benefits And Improved Motor Function . For further insights on this market. request a sample here

Which region has the most growth potential in the Gene Therapy On Neurological Diseases market?

North America was the largest region in the gene therapy on neurological diseases market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene therapy on neurological diseases market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.